toggle visibility Search & Display Options

Tout Sélectionner    Désélectionner
 | 
Citations
 | 

2019

Thomas, B., Duval, R. E., Fontanay, S., Varbanov, M., & Boisbrun, M. (2019). Synthesis and Antibacterial Evaluation of Bis-thiazolium, Bis-imidazolium, and Bis-triazolium Derivatives. ChemMedChem, .
toggle visibility

2018

Colin, C., Meyer, M., Cerella, C., Kleinclauss, A., Monard, G., Boisbrun, M., Diederich, M., Flament, S., Grillier-Vuissoz, I., & Kuntz, S. (2018). Biotinylation improves anticancer properties of 15d-PGJ2 against breast cancer cells. International Journal of Oncology, 52(6), 1991–2000.
toggle visibility
Meyer, M., Foulquier, S., Dupuis, F., Flament, S., Grimaud, L., Henrion, D., Lartaud, I., Monard, G., Grillier-Vuissoz, I., & Boisbrun, M. (2018). Synthesis and evaluation of new designed multiple ligands directed towards both peroxisome proliferator-activated receptor-γ and angiotensin II type 1 receptor. European Journal of Medicinal Chemistry, 158, 334–352.
toggle visibility

2017

Geoffroy, M., Kleinclauss, A., Grandemange, S., Hupont, S., Boisbrun, M., Flament, S., Grillier-Vuissoz, I., & Kuntz, S. (2017). Pro-apoptotic effect of Δ2-TGZ in “claudin-1-low” triple-negative breast cancer cells: involvement of claudin-1. Breast Cancer Res Treat, 165(3), 517–527.
toggle visibility

2016

Berthe, A., Flament, S., Grandemange, S., Zaffino, M., Boisbrun, M., & Mazerbourg, S. (2016). Δ2-Troglitazone promotes cytostatic rather than pro-apoptotic effects in breast cancer cells cultured in high serum conditions. Cell Cycle, 15(24), 3402–3412.
toggle visibility
Tout Sélectionner    Désélectionner
 | 
Citations
 |